Press Releases Investors Investors Overview News & Events Overview Press Releases IR Calendar Email Alerts Company Info Overview Presentations Contacts FAQ Financial Info Overview Financial Results Income Statement Balance Sheet Cash Flow Stock Data Quote Charts Historical Data SEC Filings Overview All SEC Filings Annual Reports Quarterly Reports Section 16 Filings Governance Board Committees Governance Documents News & Events Overview Press Releases IR Calendar Email Alerts Year All Years 2022 2021 2020 2019 2018 2017 2016 2015 2014 Aug 21, 2017 9:00am EDT Medovex Corporation Appoints Gorlin Companies Managing Partner Jesse Crowne Director and Executive Co-Chairman of the Board Aug 17, 2017 12:50pm EDT Medovex Corporation Names Charlie Farrahar Chief Financial Officer Aug 07, 2017 10:50am EDT Medovex Corporation DenerveX System Completes First Human Case in Italy Aug 01, 2017 8:30am EDT Medovex Corporation DenerveX System Reports on First Two Completed Cases in Germany Jul 25, 2017 8:00am EDT Medovex Corporation DenerveX System First Cases to Commence in Germany Jul 17, 2017 8:00am EDT Medovex Corporation Announces Pricing of $2.69 Million Concurrent Registered Direct Offering and Private Placement Jul 05, 2017 8:00am EDT Medovex Corporation Updates European Union Launch Progress Jun 27, 2017 8:30am EDT Medovex Corporation Schedules First Human Case for DenerveX(TM) System Jun 16, 2017 9:50am EDT Medovex Corporation Receives First Three Commercial Orders for DenerveX(TM) System Jun 12, 2017 8:00am EDT Medovex Corporation Releases Letter to Shareholders Prev 1 2 3 4 5 6 7 8 9 10 ...14 Next
Aug 21, 2017 9:00am EDT Medovex Corporation Appoints Gorlin Companies Managing Partner Jesse Crowne Director and Executive Co-Chairman of the Board
Aug 01, 2017 8:30am EDT Medovex Corporation DenerveX System Reports on First Two Completed Cases in Germany
Jul 17, 2017 8:00am EDT Medovex Corporation Announces Pricing of $2.69 Million Concurrent Registered Direct Offering and Private Placement
Jun 16, 2017 9:50am EDT Medovex Corporation Receives First Three Commercial Orders for DenerveX(TM) System
